Reduced 25-hydroxyvitamin D levels in primary Sjogren's syndrome

Scandinavian Journal of Rheumatology

Volumn 28, Issue 3, 1999, Pages 180-183

  Bang, Bo ^a,c   Asmussen, K ^a   Sorensen O H ^b   Oxholm, P ^d  

^a Rigshospitalet   (Denmark)

^b Municipal Hospital ^*  (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d NONE

Author keywords

Clinical status; Primary Sjogren's syndrome; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; INTERLEUKIN 2 RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; SJOGREN'S SYNDROME; VITAMIN D;

EID: 0032990967     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009749950154266     Document Type: Article

References (15)

1. 3, J Cell Biochem 1992;49:26-31.
2. 2. Müller K, Oxholm P, Sørensen OH, Thymann M, Høier-Madsen M, Bendtzen K. Abnormal vitamin D3 metabolism in patients with primary Sjögrens's syndrome. Ann Rheum Dis 1990;49:682-4.
3. 3. Asmussen K, Andersen V, Bendixen G, Schiødt M, Oxholm P. A new model for classification of disease manifestations in primary Sjögren's syndrome: Evaluation in a retrospective long-term study. J Int Med Res 1996;239:475-82.
4. 4. Manthorpe R, Oxholm P, Prause JU, Schiødt M. The Copenhagen criteria for SjÜgren's syndrome. Scand J Rheumatol Suppl 1986;61:19-21.
5. 5. Lund Bj, Lund Bi, Sørensen OH. Measurement of circulating 1,25-dihydroxyvitamin D in man. Changes in serum concentrations during treatment with I alfa-hydoxycholecalciferol. Acta Endocrinol 1979;91:338-50.
6. 6. Lund Bj, Sørensen OH. Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin D intake in the Danish population. Scand J Clin Lab Invest 1979;39:23-30.
7. 7. Asmussen K, Andersen V, Bendixen G, Prause JU, Thorn J, Wiik A, et al. Quantitative Assessment of Clinical Disease Status in Primary Sjögren's syndrome. Scand J Rheumatol 1997;26:197-205.
8. 8. Moutsopoulos HM. Sjögren's syndrome: Autoimmune epithelitis. Clin Immunol Immunopathol 1994;72:162-5.
9. 9. Oxholm P, Asmussen K. Primary Sjögren's syndrome: The challenge for classification of disease manifestations. J Int Med 1996;239:467-74.
10. 3 in patients with Systemic Lupus Erythematosus. Clin Rheumatol 1995;14:397-400.
11. 11. Als OS, Riis B, Christiansen C. Serum concentrations of vitamin D metabolites in rheumatoid arthritis. Clin Rheumatol 1987;6:238-43.
12. 12. Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL. Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1,25 dihydroxyvitamin D3. N Engl J Med 1981;305:440-3.
13. 3in patients with inflammatory arthritis. J Bone Minor Res 1991;6:733-38.
14. 14. Glijer B, Peterfy C, Tenenhouse A. The effect of vitamin D deficiency on secretion by rat parotid gland in vivo. J Physiol (London) 1985;363:323-34.
15. 15. Peterfy C, Tenenhouse A, Yu E. Vitamin D and parotid gland function in the rat. J Physiol (London) 1988;398:1-13.